Taiko Pharmaceutical Co., Ltd. (4574) Press Release
Notice Concerning Application for a Market Division Change to the Tokyo Stock Exchange Standard Market
Earlier from Taiko Pharmaceutical
- Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2026 (FY2026)
- Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2026 (Under Japanese GAAP)
- TABLE-Taiko Pharmaceutical -2025 group results
- TABLE-Taiko Pharmaceutical - 9-MTH group results